MHRA announces Good Clinical Practice (GCP) Discussion Forum
The U.K. Medicines and Healthcare products Regulatory Agency MHRA has created a GCP Discussion Forum to help all those involved in the conduct of clinical trials implement quality procedures that can ensure compliance with clinical trials legislation and GCP requirements.
The platform also provides the ideal opportunity for an extended communication between researchers and allows users to put forward their comments and get 'real-life' examples.
Related GMP News
03.06.2026In-use Storage Time of Reconstituted Medicines
28.05.2026New EMA Q&A on the Implementation of 3DP Technology
28.05.2026EMA publishes Presentations on Contractual Agreements in Clinical Trials
28.05.2026UK Substantial Modifications Pilot
07.05.2026What are the GMP Requirements for Investigational Medicinal Products (IMPs)?